Pubblicazioni

Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after â¥1 prior tyrosine kinase inhibitor: 2-year follow-up results

2024 - LEUKEMIA

Cortes, Jorge E.; Sasaki, Koji; Kim, Dong-Wook; Hughes, Timothy P.; Etienne, Gabriel; Mauro, Michael J.; Hochhaus, Andreas; Lang, Fabian; Heinrich, Michael C.; Breccia, Massimo; Deininger, Michael; Goh, Yeow Tee; Janssen, Jeroen J. W. M.; Talpaz, Moshe; de Soria, Valle Gomez Garcia; le Coutre, Philipp; Deangelo, Daniel J.; Damon, Andrea; Cacciatore, Silvia; Polydoros, Fotis; Agrawal, Nithya; Rea, Delphine

Understanding and overcoming resistance to tyrosine kinase inhibitors (TKIs) in Chronic myeloid leukemia (CML)

2024 - EXPERT REVIEW OF HEMATOLOGY

LaganÃ , Alessandro; Scalzulli, Emilia; Bisegna, Maria Laura; Ielo, Claudia; Martelli, Maurizio; Breccia, Massimo

Pubblicazioni

Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after â¥1 prior tyrosine kinase inhibitor: 2-year follow-up results

Understanding and overcoming resistance to tyrosine kinase inhibitors (TKIs) in Chronic myeloid leukemia (CML)

Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after â¥1 prior tyrosine kinase inhibitor: 2-year follow-up results